Pharmaceuticals company Natco Pharma announced Q2FY26 results Consolidated total revenue of Rs 1,463.0 crore for Q2FY26 as against Rs 1,434.9 crore as of 30th September 2024. EBITDA (including other income) for the quarter was at Rs 679.2 crore with margins at 46.4%. The net profit for the period, on a consolidated basis was Rs 517.9 crore. The Board of Directors have declared an interim dividend of Rs 1.5 per equity share of Rs 2 each during Q2FY26. Result PDF
